SMN1 and spinal muscular atrophy: Spinal Muscular Atrophy (SMA): One of the most successful applications of RNA therapeutics in rare genetic diseases is the treatment of spinal muscular atrophy (SMA), a neurodegenerative disorder caused by mutations in the SMN1 gene.